Members Members Residents Job Board
Join Today Renew Your Membership Make A Donation
Modulators of Ceramide Metabolism Sensitize Colorectal Cancer Cells to Chemotherapy: A Novel Treatment Strategy

Abstracts
2002 Digestive Disease Week

# 100799 Abstract ID: 100799 Modulators of Ceramide Metabolism Sensitize Colorectal Cancer Cells to Chemotherapy: A Novel Treatment Strategy
David A Litvak, Anton J Bilchik, Myles C Cabot, Santa Monica, CA

Introduction. Resistance to chemotherapy is a major treatment obstacle for advanced colorectal cancer (CRC). We have shown previously that chemosensitivity correlates with formation of the apoptosis-inducing lipid ceramide, while chemoresistance correlates with formation of the non-cytotoxic metabolite glucosylceramide (GlcCer) in several types of cancer cells. Our study assessed the role of ceramide in chemotherapy-mediated CRC cell death. Methods. Using the human CRC cell lines HT-29 and CeNU (established in our lab), we assessed the effects of irinotecan (CPT-11) on ceramide metabolism, cell viability, and apoptosis. Fumonisin B1 (FB1) was used to block ceramide synthesis, and 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol (PPMP) to block metabolism of ceramide to GlcCer. Safingol was used to block secondary ceramide-activated protein kinase-C-mediated proliferative pathways. Statistical significance was assessed by ANOVA. Results. Irinotecan caused a 300% increase in ceramide (p<0.05), which preceded apoptosis in both cell lines; however, cell viability was restored by adding FB1 to block ceramide synthesis. The ~40% of cells that remained viable after treatment with irinotecan demonstrated increased levels of GlcCer (~50% over untreated cells; p<0.05). When GlcCer synthesis was blocked with PPMP in HT-29 cells, levels of ceramide were significantly increased and cell death was enhanced. Moreover, when PPMP and safingol were combined with irinotecan in both cell lines, cell death was increased in a synergistic fashion, compared to irinotecan alone (p<0.01) (Fig. 1; HT-29 cells). Conclusions. The cytotoxic effects of irinotecan are mediated by ceramide and may be enhanced by blocking ceramide metabolism. Targeting ceramide metabolism is a novel and potentially effective treatment strategy for advanced CRC.





Society for Surgery of the Alimentary Tract

Facebook Twitter YouTube

Email SSAT Email SSAT
500 Cummings Center, Suite 4400, Beverly, MA 01915 500 Cummings Center
Suite 4400
Beverly, MA 01915
+1 978-927-8330 +1 978-927-8330
+1 978-524-0498 +1 978-524-0498
Links
About
Membership
Publications
Newsletters
Annual Meeting
Join SSAT
Job Board
Make a Pledge
Event Calendar
Awards